Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

Rheumatology (United Kingdom)

Volumn 51, Issue 9, 2012, Pages 1563-1570

  Gono, Takahisa ^a   Sato, Shinji ^b   Kawaguchi, Yasushi ^a   Kuwana, Masataka ^c   Hanaoka, Masanori ^a   Katsumata, Yasuhiro ^a   Takagi, Kae ^a   Baba, Sayumi ^a   Okamoto, Yuko ^a   Ota, Yuko ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti MDA5 antibody; Dermatomyositis; Ferritin; Interleukin 18; Interstitial lung disease

Indexed keywords

FERRITIN; INTERLEUKIN 18; MDA5 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

AUTOANTIBODIES; CALCINEURIN; CYCLOSPORINE; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; FEMALE; FERRITINS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-18; JAPAN; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865317248     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes102     Document Type: Article

References (29)

1. Callen J. Dermatomyositis. Lancet 2000;355:53-7.
2. Nobutoh T, Kohda M, Doi Y, Ueki H. An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998;25:32-6.
3. Tsuda T, Asanuma Y, Koyama S, Kawabata Y, Moriguchi M. A case of hypomyopathic dermatomyositis associated with rapid progressive interstitial pneumonia resistant to multi-immunosuppressive therapy. Am J Med Sci 2007;333:185-90.
4. Kameda H, Nagasawa H, Ogawa H et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005;32:1719-26.
5. Ito M, Kaise S, Suzuki S et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 1999;18:462-7.
6. Gerami P, Schope J, McDonald L, Walling H, Sontheimer R. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sinémyositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006;54:597-613.
7. Sato S, Hoshino K, Satoh T et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009; 60:2193-200.
8. Nakashima R, Imura Y, Kobayashi S et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2010;49:433-40.
9. Gono T, Kawaguchi Y, Satoh T et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010;49:1713-9.
10. Sato S, Hirakata M, Kuwana M et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
11. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008;20:17-22.
12. Gono T, Kawaguchi Y, Hara M et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010;49:1354-60.
13. Gono T, Kawaguchi Y, Sugiura T et al. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. Rheumatology 2010;49:1878-81.
14. Henter J, Horne A, Aricó M et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48: 124-31.
15. Tristano A. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit 2008;14:RA27-36.
16. Bohan A, Peter J. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
17. Sontheimer R. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sinémyositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002;46: 626-36.
18. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646-64.
19. Suda T, Fujisawa T, Enomoto N et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 2006;28:1005-12.
20. Fathi M, Vikgren J, Boijsen M et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008;59:677-85.
21. Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 2010;22:639-43.
22. Ye S, Chen X, Lu X et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 2007;26:1647-54.
23. Mukae H, Ishimoto H, Sakamoto N et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009;136:1341-7.
24. Gono T, Kawaguchi Y, Ozeki E et al. Serum ferritin correlates with activity of anti-MDA5 antibodyassociated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 2011; 21:223-7.
25. Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease. Arthritis Rheum 2001;44:1716-7.
26. Okamura H, Tsutsi H, Komatsu T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
27. Tucci M, Quatraro C, Dammacco F, Silvestris F. Increased IL-18 production by dendritic cells in active inflammatory myopathies. Ann N Y Acad Sci 2007;1107: 184-92.
28. Ward P, Hunninghake G. Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998;157(4 Pt 2):S123-9.
29. Christensen M, Pachman L, Schneiderman R, Patel D, Friedman J. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986;29:1365-70.